Guggenheim reissued their buy rating on shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) in a report published ...

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the firm, Marketbeat Ratings ...

On this episode of The Long View, Dr. Jay Zigmont, author and founder and CEO of Childfree Wealth, breaks down how childfree people can plan their finances and key takeaways from his new book, The ...